HSP90AB1 and uveal melanoma: Subsequent studies with cutaneous and uveal melanoma cells [17, 18, 37, 38] have suggested that BRAFV600E is more sensitive to 17-AAG-induced degradation than BRAFWT, a suggestion that has been attributed to preferential or exclusive association of BRAFV600E rather than BRAFWT with HSP90.